Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replacing v3.4.2. This appears to be a system/UI update with no changes to the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:48:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removal of the general government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice banner was added. The site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:23:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page updated with a new 'Show glossary' option, capitalization adjustments for QC labels ('Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a revision bump to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:18:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The site revision label in the footer was updated from Revision: v3.3.3 to Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T02:21:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T13:31:06.000Z thumbnail image

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.